Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function
β Scribed by Jones, Natalie C; Lynn, Megan L; Gaudenz, Karin; Sakai, Daisuke; Aoto, Kazushi; Rey, Jean-Phillipe; Glynn, Earl F; Ellington, Lacey; Du, Chunying; Dixon, Jill
- Book ID
- 109933120
- Publisher
- Nature Publishing Group
- Year
- 2008
- Tongue
- English
- Weight
- 579 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1078-8956
- DOI
- 10.1038/nm1725
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Resistance to cisplatinβbased chemotherapy is a major cause of treatment failure in human ovarian cancer. Wildβtype __TP53__ status is often, but not always, associated with cisplatin sensitivity, suggesting that additional factors may be involved. Overexpression/activation of the phosp
## Abstract We report that MDM2, a negative regulator of p53, can bind to EBNAβ5. Using GST pullβdown assay, immunoprecipitation, surface plasmon resonance and immunostaining of lymphoblastoid cells, we found that trimolecular complexes are formed between EBNAβ5, MDM2 and p53, where MDM2 serves as
Overexpression of P-glycoprotein (Pgp) is one of the major limitations in cancer chemotherapy. Previous work has shown that amphiphilic diblock copolymers composed of methoxypolyethylene glycol-block-polycaprolactone (MePEG-b-PCL) diblock copolymers enhanced the cellular accumulation of Pgp substrat